| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PONE.0191109 |
| P8608 | Fatcat ID | release_u2qg33nj7vd5bk32icq3vgokva |
| P932 | PMC publication ID | 5802492 |
| P698 | PubMed publication ID | 29415026 |
| P50 | author | Takanori Eguchi | Q88695175 |
| P2093 | author name string | Hirohiko Okamura | |
| Masaharu Takigawa | |||
| Ken-Ichi Kozaki | |||
| Stuart K Calderwood | |||
| Tetsuya Nakatsura | |||
| Jun Murakami | |||
| Manami Shimomura | |||
| Kenta Uchibe | |||
| Chiharu Sogawa | |||
| Kuniaki Okamoto | |||
| Manabu Itoh | |||
| Kazumi Ohyama | |||
| Kazuya Arai | |||
| Keisuke Nakano | |||
| Kisho Ono | |||
| Ryosuke Iinuma | |||
| Toshifumi Fujiwara | |||
| Yoshiki Murata | |||
| Yuka Okusha | |||
| Yuri Namba | |||
| P2860 | cites work | Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and c-myb promoter activity | Q40017527 |
| Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer | Q40059974 | ||
| Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer | Q40236483 | ||
| Identification of genes involved in tumor-like properties of embryonic stem cells | Q40254961 | ||
| Induction of heat shock proteins in B-cell exosomes. | Q40392853 | ||
| Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. | Q40563114 | ||
| STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells . | Q40905638 | ||
| γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation | Q41057828 | ||
| Probing the Diversity of T Cell Dysfunction in Cancer | Q41098734 | ||
| Establishment and characterization of high- and low-lung-metastatic cell lines derived from murine colon adenocarcinoma 26 tumor line | Q41253803 | ||
| Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis | Q42171605 | ||
| Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing | Q42438370 | ||
| De-novo expression of CD44 and survival in gastric cancer | Q42483834 | ||
| Active macropinocytosis induction by stimulation of epidermal growth factor receptor and oncogenic Ras expression potentiates cellular uptake efficacy of exosomes | Q42755820 | ||
| Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells | Q42806657 | ||
| Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures | Q43249115 | ||
| Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability | Q22242922 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma | Q24296639 | ||
| DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth | Q24303568 | ||
| CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer | Q24318416 | ||
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing | Q24321530 | ||
| The Hippo Signaling Pathway in Development and Cancer | Q24603986 | ||
| miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
| Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells | Q24624032 | ||
| The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations | Q24646816 | ||
| A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells | Q24649109 | ||
| Cellular Reprogramming Using Defined Factors and MicroRNAs | Q26744303 | ||
| Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity | Q26747413 | ||
| Extracellular vesicle transfer of cancer pathogenic components | Q26770045 | ||
| STING: infection, inflammation and cancer | Q26776009 | ||
| Therapeutic strategies targeting cancer stem cells | Q26781398 | ||
| Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally | Q26991472 | ||
| Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues | Q27023837 | ||
| The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment | Q27025661 | ||
| HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression | Q27025886 | ||
| A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516 | Q27323906 | ||
| Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules | Q27333594 | ||
| Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb. | Q50797309 | ||
| Intracellular MMP3 Promotes HSP Gene Expression in Collaboration With Chromobox Proteins. | Q53097440 | ||
| The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. | Q54298179 | ||
| Expression of CD44R1 adhesion molecule in colon carcinomas and metastases | Q72213003 | ||
| Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 | Q74033284 | ||
| Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 | Q78701428 | ||
| Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens | Q80099843 | ||
| The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer | Q80502357 | ||
| Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas | Q93621132 | ||
| Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications | Q37735627 | ||
| TGFbeta signalling: a complex web in cancer progression | Q37760038 | ||
| Redox regulation in stem-like cancer cells by CD44 variant isoforms. | Q38075424 | ||
| The Hippo pathway and human cancer. | Q38087215 | ||
| Stress proteins in aging and life span | Q38112457 | ||
| LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms | Q38281095 | ||
| Cdc37 as a co-chaperone to Hsp90. | Q38285298 | ||
| The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity | Q38301987 | ||
| Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. | Q38311270 | ||
| The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence | Q38536374 | ||
| HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. | Q38735527 | ||
| Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer | Q38768101 | ||
| Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. | Q38769897 | ||
| Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. | Q38941237 | ||
| Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. | Q38964131 | ||
| ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy | Q39143201 | ||
| MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma | Q39150597 | ||
| EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | Q39233875 | ||
| Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation | Q39262830 | ||
| Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets | Q39385550 | ||
| Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis | Q39441340 | ||
| TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. | Q39451094 | ||
| The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation | Q39530908 | ||
| MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. | Q39996214 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses | Q28068802 | ||
| Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation | Q28081553 | ||
| Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions | Q28088370 | ||
| mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis | Q28116279 | ||
| Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts | Q28146071 | ||
| Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter | Q28208212 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| The emerging role of EpCAM in cancer and stem cell signaling | Q28251164 | ||
| The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling | Q28252084 | ||
| Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene | Q28263327 | ||
| The clonal evolution of tumor cell populations | Q28271546 | ||
| Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update | Q28272905 | ||
| Targeting the dynamic HSP90 complex in cancer | Q28288602 | ||
| Pharmacogenomic discovery using cell-based models | Q28392982 | ||
| KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer | Q28594330 | ||
| Clonal evolution in cancer | Q29547696 | ||
| Prospective identification of tumorigenic prostate cancer stem cells | Q29547859 | ||
| Drug resistance and the solid tumor microenvironment | Q29614403 | ||
| Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing | Q29614647 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Accessories to the crime: functions of cells recruited to the tumor microenvironment | Q29620161 | ||
| NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells | Q30417710 | ||
| Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. | Q30481878 | ||
| Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. | Q30497855 | ||
| CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients | Q30584751 | ||
| The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer | Q33451434 | ||
| The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis | Q33769624 | ||
| Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells | Q33794176 | ||
| Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles | Q33935224 | ||
| High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer | Q34118497 | ||
| The plasminogen activator/plasmin system | Q34202297 | ||
| Interactions between cancer stem cells and their niche govern metastatic colonization | Q34239769 | ||
| miRNA-720 controls stem cell phenotype, proliferation and differentiation of human dental pulp cells | Q34395505 | ||
| The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities | Q34399306 | ||
| Evolution of the cancer stem cell model | Q34408981 | ||
| The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis | Q34421800 | ||
| Hypoxia-inducible factors, stem cells, and cancer | Q34625782 | ||
| CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 | ||
| OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells | Q34637681 | ||
| Exosomes as divine messengers: are they the Hermes of modern molecular oncology? | Q34675263 | ||
| HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression | Q34765945 | ||
| Targeting tumor-associated macrophages as a novel strategy against breast cancer | Q34803221 | ||
| Spherical cancer models in tumor biology | Q35023931 | ||
| Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production | Q35142842 | ||
| Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells | Q35238399 | ||
| Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP | Q35436566 | ||
| The role of Notch in tumorigenesis: oncogene or tumour suppressor? | Q35564593 | ||
| β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. | Q35585837 | ||
| Hsp90 molecular chaperone inhibitors: are we there yet? | Q35655105 | ||
| Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer | Q35768332 | ||
| TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. | Q35830257 | ||
| Hsp90α and Hsp90β together operate a hypoxia and nutrient paucity stress-response mechanism during wound healing | Q35898804 | ||
| Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro | Q35939788 | ||
| Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. | Q35989886 | ||
| Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes | Q36010700 | ||
| Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability | Q36173954 | ||
| PC3 is a cell line characteristic of prostatic small cell carcinoma. | Q36185201 | ||
| Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer | Q36293646 | ||
| Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways | Q36313178 | ||
| Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. | Q36368188 | ||
| MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B | Q36686246 | ||
| Unusual and underappreciated: small cell carcinoma of the prostate. | Q36725653 | ||
| MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches | Q36753508 | ||
| TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. | Q36907085 | ||
| SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b | Q36968417 | ||
| Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model | Q37438615 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| organoid | Q11293125 | ||
| P304 | page(s) | e0191109 | |
| P577 | publication date | 2018-02-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment | |
| P478 | volume | 13 |
| Q92089516 | 3D Cellular Architecture Affects MicroRNA and Protein Cargo of Extracellular Vesicles |
| Q90045737 | 3D cell culture stimulates the secretion of in vivo like extracellular vesicles |
| Q97422014 | 3D culture technologies of cancer stem cells: promising ex vivo tumor models |
| Q90162116 | A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs |
| Q92051086 | Advances in therapeutic applications of extracellular vesicles |
| Q90418846 | Alcohol Exposure Impacts the Composition of HeLa-Derived Extracellular Vesicles |
| Q89896564 | Antiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3 |
| Q90598634 | Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells |
| Q92154779 | Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy |
| Q90270928 | Cockle Shell-Derived Aragonite CaCO3 Nanoparticles for Co-Delivery of Doxorubicin and Thymoquinone Eliminates Cancer Stem Cells |
| Q58576093 | Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells |
| Q94553421 | Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer |
| Q102141394 | Exosomes and breast cancer drug resistance |
| Q94601218 | Exosomes in osteoarthritis and cartilage injury: advanced development and potential therapeutic strategies |
| Q104500575 | Extracellular heat shock proteins and cancer: New perspectives |
| Q64972659 | Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors. |
| Q90080306 | Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond |
| Q93052187 | Immunological Outcomes Mediated Upon Binding of Heat Shock Proteins to Scavenger Receptors SCARF1 and LOX-1, and Endocytosis by Mononuclear Phagocytes |
| Q92127472 | Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells |
| Q92636704 | MZF1 and SCAND1 Reciprocally Regulate CDC37 Gene Expression in Prostate Cancer |
| Q99634882 | Organoids in Translational Oncology |
| Q90163791 | Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion |
| Q59806470 | The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles |
Search more.